Future Leaders Fellowships: Round 5 Interview Panel Membership

Total Page:16

File Type:pdf, Size:1020Kb

Future Leaders Fellowships: Round 5 Interview Panel Membership Future Leaders Fellowships: Round 5 Interview Panel Membership Panel Chairs Franklin Aigbirhio, University of Cambridge Lene Hviid, Shell Global Solutions International B.V Veronica Bowman, Dstl Ruth Livesey, Royal Holloway, University of Nessa Carey, Independent London John Crawford, University of Glasgow Barbara Mable, University of Glasgow Alastair Edge, Durham University Sita Popat-Taylor, University of Leeds Gordon Harold, University of Cambridge Eleanor Riley, University of Edinburgh Steve Harris, BAE Systems Kate Royse, NERC British Geological Survey James Hegarty, Cardiff University John Stairmand, Jacobs UK Ltd Steve Hill, University of Nottingham David Thomas, University of Helsinki Simon Hollingsworth, AstraZeneca Fiona Tomley, University of Edinburgh Panel Members Zulfiqur Ali, Teeside University Claude Chibelushi, Semantics21 Jennifer Allen, University of Bath Andrew Coates, University College London Helen Balinsky, HP Paul Cooke, University of Leeds Charles Bangham, Imperial College London Jenny Cooper, Independent Lisa Belyea, Queen Mary University of Antonella De Santo, University of Sussex London Anne Delille, Centre for Process Innovation Roger Bromley, University of Huddersfield Limited Emmanuel Brousseau, Cardiff University Urska Demsar, University of St Andrews Anthony Brown, Carrick Therapeutics Tao Dong, University of Oxford Philippa Browning, The University of Ruth Dundas, University of Glasgow Manchester Anton Edwards, Sustainable Aquaculture Olwyn Byron, University of Glasgow Innovation Centre Paul Evans, University of Sheffield Nicola Pearsall, Northumbria University Stuart Farrow, Cancer Research UK Michelle Peckham, University of Leeds Antonio Feteira, Sheffield Hallam University Roger Pickup, Lancaster University Yang Gao, University of Surrey Richard Price, Pragmatic Tech Sarah Gaunt, SPG Innovation David Pyle, University of Oxford Rachael Gooberman-Hill, University of Bristol Ian Reid, Siloton John Greenman, University of Hull Ian Rivers, University of Strathclyde Tim Griffiths, Newcastle University Yvonne Rogers, University College London Giles Hammond, University of Glasgow Olivia Rossanese, Institute for Cancer Research Rosie Harding, University of Birmingham Anne Rosser, Cardiff University Alwyn Hart, Environment Agency Valerio Rossi, Unit9 John Haycock, University of Sheffield Anthony Rowbottom, Lancashire Teaching Ben Johnson, Graphic Science Hospitals NHS Trust Pavlos Lagoudakis, University of Marc Sarzi, Armagh Observatory Southampton Hazel Screen, Queen Mary University of Colin Lambert, Lancaster University London Jonathan Legh-Smith, BT Louise Serpell, University of Sussex Andrew Linn, University of Westminster Trevor Sharp, University of Oxford Darshini Mahadevia, CEPT University Sarah Sharples, University of Nottingham Erika Mancini, University of Sussex David Shilston, Atkins Global Wellington Masamba, Botswana International Ravi Silva, University of Surrey University Alison Sinclair, University of Sussex Sven Mattys, University of York Malcolm Skingle, GSK Anne McArdle, University of Liverpool Gabriela Slavcheva, Quantopticon Ltd Peter McNaughton, King's College London Tom Stephenson, Cranfield University David Mela, Retired (formerly Unilever) Andrea Streit, King’s College London Nicole Metje, University of Birmingham Allan Sudlow, The British Library Jocelyn Monroe, Royal Holloway, University of London Stephen Sweeney, University of Surrey Florence Mtambanengwe, University of Eriko Takano, The University of Manchester Zimbabwe Krasimira Tsaneva-Atanasova, University of Linda Mulcahy, University of Oxford Exeter Ian Newington, LGC Ltd Tina van de Flierdt, Imperial College London Joanna Norman, V&A Sarah Vickerstaff, University of Kent Shane O'Neill, Keele University Paul Watson, Newcastle University Donald Palmer, Royal Veterinary College Jennifer Wen, University of Warwick Vivienne Parry, Genomics England Mike White, The University of Manchester Alessia Pasquazi, University of Sussex Pip Willcox, The National Archives Rachel Williams, University of Liverpool Daniel Zizzo, University of Queensland Jan Wolber, GE Healthcare Mohamed Gouiza, University of Leeds Roving Panel Members David Amigoni, Keele University Pleasantine Mill, University of Edinburgh Sam Aspinall, University of Leeds Gary Montague, Teesside University Nigel Brown, University of Edinburgh Declan Mulkeen, Imperial College London Luke Chamberlain, University of Peter Oakley, The Welding Institute Strathclyde Stefan Przyborski, Durham University Julien Cornebise, University College London Caroline Relton, University of Bristol Marie Edmonds, University of Cambridge Colin Rickman, Heriot Watt University John Girkin, Durham University Tara Shears, University of Liverpool Mark Goulding, Merck Chemicals Ltd UK Sara Shinton, University of Edinburgh Allison Jackson, University of Glasgow Sarah Spurgeon, University College London Chris Jackson, Imperial College London Yvonne Tasker, University of Leeds Mark Jefferies, Rolls-Royce Su Varma, NSG Group Julian Ketley, University of Leicester Jonathan Wastling, Keele University Fiona Matthews, Newcastle University Laura Wicks, Heriot Watt University Noha Mellor, University of Bedfordshire Organisation of panels will be responsive to the applications in each round. To ensure consistency some of the Future Leaders Fellowships Panel College will be asked to join panels for several rounds; others will be asked to join one panel per year, based on applicant demand. .
Recommended publications
  • Criteria Phase
    Criteria Phase Main Panel A 1 Clinical Medicine 2 Public Health, Health Services and Primary Care 3 Allied Health Professions, Dentistry, Nursing and Pharmacy 4 Psychology, Psychiatry and Neuroscience 5 Biological Sciences 6 Agriculture, Veterinary and Food Science Main Panel B 7 Earth Systems and Environmental Sciences 8 Chemistry 9 Physics 10 Mathematical Sciences 11 Computer Science and Informatics 12 Engineering Main Panel C 13 Architecture, Built Environment and Planning 14 Geography and Environmental Studies 15 Archaeology 16 Economics and Econometrics 17 Business and Management Studies 18 Law 19 Politics and International Studies 20 Social Work and Social Policy 21 Sociology 22 Anthropology and Development Studies 23 Education 24 Sport and Exercise Sciences, Leisure and Tourism Main Panel D 25 Area Studies 26 Modern Languages and Linguistics 27 English Language and Literature 28 History 29 Classics 30 Philosophy 31 Theology and Religious Studies 32 Art and Design: History, Practice and Theory 33 Music, Drama, Dance, Performing Arts, Film and Screen Studies 34 Communication, Cultural and Media Studies, Library and Information Management 1 CriCriteria Phase Main Panel A Chair Professor John Iredale University of Bristol Members Professor Doreen Cantrell University of Dundee Professor Peter Clegg University of Liverpool Professor David Crossman Chief Scientist Scottish Government Professor Dame Anna Dominiczak* University of Glasgow Professor Paul Elliott Imperial College London Professor Garret FitzGerald University of Pennsylvania
    [Show full text]
  • Pathways to Success in Engineering Degrees and Careers
    Pathways to success in engineering degrees and careers July 2015 Pathways to success in engineering degrees and careers c1 c2 Royal Academy of Engineering Pathways to success in engineering degrees and careers A report commissioned by the Royal Academy of Engineering Standing Committee for Education and Training July 2015 ISBN: 978-1-909327-12-2 © Royal Academy of Engineering 2015 Available to download from: www.raeng.org.uk/pathwaystosuccess Cover and opposite image courtesy of the University of Liverpool Authors Dr Tim Bullough and Dr Diane Taktak, Engineering and Materials Education Research Group at the University of Liverpool About the Engineering and Materials Education Research Group (EMERG) Established in 2011, EMERG is based in the School of Engineering at the University of Liverpool and researches, develops, shares and supports best teaching and learning practice within the University of Liverpool and nationally in 4 main areas: • research and development of specialist engineering teaching methods and technologies, with an emphasis on e-learning • development and support for academics who wish to increase their skills as professional educators • distribution of teaching materials, research findings and learning resources for universities and schools • the management of local initiatives such as overseas student support and engineering competitions. Acknowledgements We would like to express our deepest appreciation to the following people: To staff from the University of Liverpool: Jackie Leyland, Adam Mannis, Kirsty Rothwell. Staff at the Royal Academy of Engineering: Dr Rhys Morgan, Claire Donovan, Bola Fatimilehin, Dominic Nolan. Members of the project advisory group: Professor Kel Fidler, Professor Peter Goodhew and Professor Sarah Spurgeon. Members of the project focus group: Alison Brunt, Stephanie Fernandez, Andy Frost, Martin Houghton, Ed McCann, Neil Randerson, Deborah Seddon, Tammy Simmons, David Swinscoe.
    [Show full text]
  • 1520 Cell Dynamics and Immune Response to BLV Infection
    [Frontiers in Bioscience 12, 1520-1531, January 1, 2007] Cell dynamics and immune response to BLV infection: a unifying model 1 1 2 1 1 1 Arnaud Florins , Nicolas Gillet , Becca Asquith , Mathieu Boxus , Catherine Burteau , Jean-Claude Twizere , Patrice Urbain 1, Fabian Vandermeers 1, Christophe Debacq 3, Maria Teresa Sanchez-Alcaraz 4, Isabelle Schwartz-Cornil 5, Pierre Kerkhofs 6, Genèvieve Jean 7, Andre Théwis 7, Jack Hay 8, Franck Mortreux 9, Eric Wattel 9, Michal Reichert 10, 1 1 2 1,11 Arsène Burny , Richard Kettmann , Charles Bangham and Luc Willems 1 Molecular and Cellular biology, FNRS-FUSAG, Gembloux, Belgium, 2 Department of Immunology, Imperial College, London, UK, 3 GlaxoSmithKline Biologicals, Rixensart, Belgium, 4 Department of Medical Genetics and Microbiology, University of Toronto, Toronto, Canada,5 U892 INRA, Jouy-en-Josas, France, 6 Department of Virology, Veterinary and Agrochemical Research Centre, Uccle, Belgium, 7 Zootechny unit, FUSAG, Gembloux, Belgium, 8 Department of Immunology, University of Toronto, Toronto, Canada, 9 Unité d'oncogenèse virale, CNRS UMR5537 Centre Leon Bérard, Lyon, France, 10 Veterinary Research Institute, Pulawy, Poland TABLE OF CONTENTS 1. Abstract 2. Introduction 3. One pathogen in two different hosts developing related diseases 4. Strong but apparently inefficient humoral and cytotoxic immune response 5. Is the virus transcriptionally silent? The caveats of a dogma 6. How does the virus replicate? Viral replication cycle and cellular clonal expansion 7. Does the virus protect from apoptosis? The most straightforward and the alternative interpretations 8. Cell dynamics of pathogenesis in different models 9. Lymphocyte trafficking in lymphoid organs 10. Modulation of viral expression as therapy 11.
    [Show full text]
  • Newsletter President's Report This
    12/15 Engineering Professors’ Council: newsletter this issue President’s report P.1 Our year so far… New report – the role of EU membership P.2 in science and engineering research Events . Annual Congress 2015 hosted by Spending Review 2015 P.3 the University of Salford Recruitment and Admissions Forum P.3 . Annual Recruitment and Admissions Forum IMEchE Design Challenge P.4 Working with the engineers of the future P.5 20th Anniversary Student Awards Congratulations to winner Addressing the Engineering Skills Challenge P.6 Tim Butterfield of the University of Future events and membership round -up P.7 Sheffield and runner-up, PhD candidate Adrian Mallory of the University of Edinburgh. President’s Report Submitted responses and It’s been an eventful few months in the UK university sector since I took over as President at our very evidence to: successful annual Congress at the University of Salford’s Media City site in April. A major topic of . Royal Academy of Engineering’s discussion was as you might expect …the REF (I was a panel member, along with EPC Committee Dowling Review of Business colleagues Professors Alison Hodge, Sarah Spurgeon and Tony Unsworth , and so we were able to University Collaboration share our insights and experience). We also welcomed back Professor John Perkins to update us on . Department for Business, progress with the implementation of the recommendations of his 2013 Review – more of which later. Innovation and Skills’ Our student prize, which we award at Congress and give the winners the opportunity to present their consultation on Postgraduate work, was again popular this year and I’m delighted to say we’re repeating it in 2016, supported again study by the Incorporation of Hammermen of Glasgow – please do encourage your students to enter – the .
    [Show full text]
  • Reducing the Global Burden of HTLV-1 Infection: an Agenda for Research and Action
    Antiviral Research 137 (2017) 41e48 Contents lists available at ScienceDirect Antiviral Research journal homepage: www.elsevier.com/locate/antiviral Review Reducing the global burden of HTLV-1 infection: An agenda for research and action * Luc Willems a, z, , Hideki Hasegawa b, z, Roberto Accolla c, Charles Bangham d, Ali Bazarbachi e, Umberto Bertazzoni f, Anna Barbara de Freitas Carneiro-Proietti g, Hua Cheng h, Luigi Chieco-Bianchi i, Vincenzo Ciminale i, Jordana Coelho-dos-Reis j, Jose Esparza h, Robert C. Gallo h, Antoine Gessain k, Eduardo Gotuzzo l, William Hall m, Joseph Harford n, Olivier Hermine o, Steven Jacobson p, Beatrice Macchi q, Calum Macpherson r, Renaud Mahieux s, Masao Matsuoka t, Edward Murphy u, Jean-Marie Peloponese v, Viviana Simon w, Yutaka Tagaya h, Graham P. Taylor d, Toshiki Watanabe x, Yoshihisa Yamano y a University of Liege, Belgium b National Institute of Infectious Diseases, Tokyo, Japan c University of Insubria, Varese, Italy d Imperial College, London, UK e American University of Beirut, Beirut, Lebanon f University of Verona, Verona, Italy g Fundaçao~ Hemominas, Belo Horizonte, Brazil h Institute of Human Virology, Baltimore, USA i University of Padova, Padova, Italy j Rene Rachou Research Center, FIOCRUZ, Belo Brazil Horizonte, Brazil k Institut Pasteur, Paris, France l Tropical Medical Institute Alexander von Humboldt, Lima, Peru m Centre for Research in Infectious Disease, Dublin, Ireland n National Cancer Institute, NIH, Bethesda, USA o Hopital^ Necker, Paris, France p National Institute of Neurological Disorders and Stroke, NIH, Bethesda, USA q University of Rome Tor Vergata, Rome, Italy r St. George's University, Grenada s Ecole Normale Superieure de Lyon, Lyon, France t Kyoto University, Kyoto, Japan u University of California, San Francisco, USA v University of Montpellier, Montpellier, France w Icahn School of Medicine at Mount Sinai, New York, USA x University of Tokyo, Tokyo, Japan y St.
    [Show full text]
  • The Role of Killer Immunoglobulin-Like Receptors In
    The role of killer immunoglobulin-like receptors in HTLV-1 infection A thesis submitted to Imperial College London for the degree of Doctor of Philosophy By Katie R. Twigger Imperial College London 2014 Section of Immunology Department of Medicine Wright-Fleming Institute Imperial College Norfolk Place London W2 1PG Declaration of originality and copyright Copyright The copyright of this thesis rests with the author and is made available under a Creative Commons Attribution-Non Commercial-No Derivatives licence. Researchers are free to copy, distribute or transmit the thesis on the condition that they attribute it, that they do not use it for commercial purposes and that they do not alter, transform or build upon it. For any reuse or distribution, researchers must make clear to others the licence terms of this work. Declaration of originality All work presented in this thesis is the author’s own other than where clearly stated in the ‘Statement of Collaboration’. Signature________________ Date____________________ 2 Summary Human T-lymphotropic virus type 1 (HTLV-1) causes the debilitating neuroinflammatory disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in a minority of infected individuals, while the majority are lifelong asymptomatic carriers (ACs). The effectiveness of the CD8+ T-cell response to HTLV-1 is a major determinant of the HTLV-1 proviral load (PVL) and the associated HAM/TSP risk. Host genotype, particularly of HLA class I, strongly influences CD8+ T-cell effectiveness against HTLV-1. Furthermore, possession of the KIR gene 2DL2 was recently shown to enhance protective and detrimental HLA class I-associated immunity to HTLV-1 and HCV (Seich al Basatena et al., 2011).
    [Show full text]
  • Vitamin D Promoted As Potential Defence Against Coronavirus | Financial Times
    04/07/2020 Vitamin D promoted as potential defence against coronavirus | Financial Times Coronavirus pandemic Vitamin D promoted as potential defence against coronavirus But scientists say more research is needed to prove whether ‘sunshine’ supplements can fight off Covid- 19 © Enrique Calvo/Reuters Clive Cookson in London 43 MINUTES AGO Calls are growing for people to take vitamin D supplements to reduce the risk of contracting Covid-19, as some research suggests they could be especially beneficial to those with darker skin. This week people in the UK were urged to make sure they were consuming enough vitamin D by three influential organisations, including the government’s Scientific Advisory Commission on Nutrition. But even advocates of the “sunshine vitamin” — so called because the body makes it in the skin through exposure to sunlight — say more evidence is needed to prove definitively that it cuts the risk of coronavirus infection and severity of symptoms. Vitamin D, a steroid hormone, is essential for maintaining a healthy immune system. In mid-latitude countries such as the UK, people with pale skin can make enough of it during summer by exposing bare arms or legs to sunlight for a few minutes a day. The process takes longer in those with heavily pigmented skin that blocks more UltraViolet radiation from the sun. In winter all our vitamin D has to come from foods, such as oily fish, egg yolks and mushrooms, or pills. https://www.ft.com/content/932920f9-f9ae-414a-940f-602169ee620f 1/3 04/07/2020 Vitamin D promoted as potential defence against coronavirus | Financial Times Other reports promoting vitamin D came from the National Institute for Health and Care Excellence and the Royal Society, Britain’s senior scientific body.
    [Show full text]
  • Thinking Like an Engineer Implications for the Education System
    Thinking like an engineer Implications for the education system May 2014 Thinking like an engineer Implications for the education system A report for the Royal Academy of Engineering Standing Committee for Education and Training Full report, May 2014 ISBN: 978-1-909327-08-5 © Royal Academy of Engineering 2014 Available to download from: www.raeng.org.uk/thinkinglikeanengineer Authors Acknowledgements Professor Bill Lucas, Dr Janet Hanson, We have been greatly helped by a number of Professor Guy Claxton, Centre for Real- people who gave their time and thinking extremely World Learning generously. In particular we would like to thank: The education team at the Royal Academy of About the Centre for Real-World Learning (CRL) Engineering at the University of Winchester Dr Rhys Morgan, Stylli Charalampous, Claire Donovan, CRL is an innovative research centre working closely with Bola Fatimilehin, Professor Kel Fidler and Dominic Nolan practitioners in education and in a range of vocational contexts. It is especially interested in new thinking and A group of experts who oered helpful advice innovative practices in two areas: on all aspects of the research and attended two workshops n The science of learnable intelligence and the implementation of expansive approaches to Heather Aspinwall, David Barlex, Jayne Bryant, education Professor José Chambers, Andrew Chater, Linda Chesworth, Dr Robin Clark, Dr Ruth Deakin Crick, n The eld of embodied cognition and its implications Claire Dillon, Professor Neil Downie, Joanna Evans, for practical learning
    [Show full text]
  • Oxford Medicine Newsletter December 2020
    Oxford Medicine THE NEWSLETTER OF THE OXFORD MEDICAL ALUMNI OXFORD MEDICINE • DECEMBER 2020 Professor COVID Vaccines Frontline Osler Rowing Ledingham Perspectives Revival 91 Not Out! And much more... Pictured: Professor John Ledingham 2 / OXFORD MEDICINE DECEMBER 2020 President’s Piece Vaccines for COVID-19 3 So much is at stake. We stand at an extraordinary Prof Charles Bangham inflection point. But where to start? Professor John GG Ledingham - 7 ‘I would adopt an A to E approach’ is the phrase 91 Not Out! currently used by young doctors when faced with a catastrophic problem, or when they have The Spirit of Brexit: Past, Present and 10 no idea what to do. I tried it with this edition: Future - Prof Alastair Buchan A - Anatomy and Augmented Reality; B -Brexit; Augmented Reality for Anatomy C - COVID…then I thought about an approach I 12 Dr Matthew Williams and Mr Tom Cosker Dr Lyn Williamson used as a young house physician - ‘What would OMA President J Led do?’ Frontline Perspectives - Prof Chris 14 Professor John Ledingham is one of Oxford’s Conlon (Oxford Update), Prof Neil Mortenen great clinicians and teachers. He has inspired generations of doctors, (Surgery), Dr Sarah Lowndes (Oncology), Dr including many who have contributed to this edition. He shares Will Seligman (ICU Reg), Dr Hannah Thould memories of his career in an interview which is warm and honest, (SHO), Dr Bernard Bukala (F1) spiced with pithy anecdotes and words of wisdom. This interview Alumni Letters 21 introduces ‘Recollecting Oxford Medicine,’ a 10-year project by Dr 'Memories from the Wittery' (Dr Carole Derek Hockaday and Dr Peggy Frith to preserve an oral history of Robertson) Oxford medicine through interviews, archived as podcasts in the Bodleian library.
    [Show full text]
  • Round 5 Sift Panel Membership
    Future Leaders Fellowships: Round 5 Sift Panel Membership Panel Chairs Nessa Carey, Independent/PraxisUnico Elaine Martin, University of Leeds John Crawford, University of Glasgow Jane Pavitt, Kingston University Marie Edmonds, University of Cambridge Rab Prinjha, GSK Gordon Harold, University of Cambridge Eleanor Riley, University of Edinburgh Stephen Hill, University of Nottingham Kate Royse, British Geological Survey Jonathan Legh-Smith, BT Tara Shears, University of Liverpool Ruth Livesey, Royal Holloway, University of John Stairmand, The Wood Group London Panel Members Anthony Brown, Carrick Therapeutics Clarisse Aichelburg, Zinc Jonathan Butterworth, University College Franklin Aigbirhio, University of Cambridge London Sitara Swarna Rao Ajjampur, Christian Olwyn Byron, University of Glasgow Medical College Vellore Yimin Chao, University of East Anglia Jennifer Allen, University of Bath Claude Chibelushi, Semantics 21 Luke Alphey, The Pirbright Institute Jonathan Chubb, University College London David Amigoni, Keele University Cathie Clarke, University of Cambridge Phil Ashworth, University of Brighton Richard Codgell, University of Glasgow A. Bahaj, University of Southampton Ramon Fernando Colmenares-Quintero, Helen Balinsky, HP Research Laboratories Cooperative University of Colombia Matt Ball, Thales UK Limited Patricia Connolly, University of Strathclyde Cristina Banks-Leite, Imperial College London Paul Cooke, University of Leeds Jennifer Barclay, University of East Anglia Tony Corkett, CTOi Ian Barnes, Natural History Museum
    [Show full text]
  • The Forgotten Cousin of HIV
    HTLV-1: The Forgotten Cousin of HIV Professor Charles Bangham HTLV-1: THE FORGOTTEN COUSIN OF HIV The catastrophic impact of HIV – human immunodeficiency virus – is well-known worldwide. Not so well known is its distant cousin HTLV-1, human T cell leukaemia virus type 1, which also has the potential to destroy lives. The study of HTLV-1 can shed light on HIV itself. A team at Imperial College London, led by Professor Charles Bangham, has been working to raise awareness of this under-researched virus and to find better treatments for the devastating illnesses that it causes. A Global Problem That Is on the Move Professor Charles Bangham, Head of the Division of Infectious Diseases at An estimated 10 million people Imperial College London, argues that worldwide are infected with the human with HTLV-1 infection becoming more T cell leukaemia virus type 1 (HTLV-1). geographically spread there is an urgent About one in ten of them eventually need to raise awareness of it among develop adult T cell leukaemia, a cancer both medical professionals and the of the blood cells, or another condition public. Professor Bangham and his called HTLV-associated myelopathy, research team are committed to raising characterised by progressive lower limb the profile of HTLV-1 and to finding more weakness and paralysis. These diseases effective treatments for those coping Colorized scanning electron micrograph typically emerge many years after initial with the long-term consequences of of a T lymphocyte. Credit: NIAID infection. Neither disease is curable, infection. both are debilitating, and the leukaemia is usually fatal despite treatment.
    [Show full text]
  • SAGE COVID-19 Register of Participants' Interests Sir Patrick Vallance FRS Fmedsci FRCP Professor Chris Whitty CB Fmedsci Prof
    SAGE COVID-19 Register of Participants’ Interests SAGE participants are required to declare any personal or business interests relevant to the SAGE meetings they attend. This register provides details of these interests. This register and the list of participants is regularly reviewed and updated. Sir Patrick Vallance FRS FMedSci FRCP • Government Chief Scientific Adviser • Office for Strategic Co-ordination of Health Research (OSCHR) Board (until 2017) • Fellow, Academy of Medical Sciences • Fellow, Royal Society • Fellow, Royal College of Physicians of London • Honorary Fellow, University College London • Honorary Member, British Pharmacological Society • Honorary Member, The Physiological Society • GSK shareholdings until March 2021 (mandatory holding period) Professor Chris Whitty CB FMedSci • Chief Medical Officer • Honorary Professor, London School of Hygiene and Tropical Medicine (LSHTM) • Consultant Physician, University College London Hospital (UCLH) • Honorary member, National Fever Service • Professor of Physic, Gresham College • Non-executive position, Malawi/Liverpool Wellcome Unit, Scientific Advisory Board • Non-executive Trustee, Sightsavers Professor Jonathan Van Tam MBE • Deputy Chief Medical Officer • Former UK Medical Director, Sanofi-Pasteur MSD Ltd. (2002-2004) • Former UK Head of Medical Affairs, Roche Products Ltd. (2001-2002) • Former Associate Director, SmithKline Beecham Plc. (2000-2001) • F. Hoffman-La Roche – Research grant on influenza (awarded 2010) • Chatham House and European Scientific Working Group on
    [Show full text]